Literature DB >> 22739957

[Folate and breast cancer risk: a systematic review].

Cecilia Castillo-L1, Josep A Tur, Ricardo Uauy.   

Abstract

An increased folate intake may be beneficial in deficient populations. However, in women with adequate levels it may not deliver additional benefits while it may increase the risk for some forms of cancer. A systematic literature review of benefits or risks of folate in the development of breast cancer was performed using MEDLINE, systematic review of selected articles and references of the selected articles looking specifically at serum folate levels, dietary folate intake or total folate intake and the risk of developing breast cancer. Fourteen case-control studies, fourteen cohort studies, seven case-control nested studies, two randomized trials and two meta-analyses were selected for analysis based on pre-established criteria. The reviewed evidence does not support the hypothesis that higher intakes of dietary folate reduce the risk for breast cancer. Some studies showed a higher risk of breast cancer in populations exposed to high folate intake post fortification, especially when folic acid is used. The results support the need to be cautious and to limit the exposure of women to high intakes of folic acid, especially in countries with mandatory food fortification.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22739957     DOI: 10.4067/S0034-98872012000200016

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  5 in total

Review 1.  Phytotherapy and Nutritional Supplements on Breast Cancer.

Authors:  C M Lopes; A Dourado; R Oliveira
Journal:  Biomed Res Int       Date:  2017-08-06       Impact factor: 3.411

Review 2.  Modification in the diet can induce beneficial effects against breast cancer.

Authors:  Felix Aragón; Gabriela Perdigón; Alejandra de Moreno de LeBlanc
Journal:  World J Clin Oncol       Date:  2014-08-10

3.  Alberta's Tomorrow Project: adherence to cancer prevention recommendations pertaining to diet, physical activity and body size.

Authors:  Heather K Whelan; Jian-Yi Xu; Sanaz Vaseghi; Geraldine Lo Siou; S Elizabeth McGregor; Paula J Robson
Journal:  Public Health Nutr       Date:  2017-01-25       Impact factor: 4.022

4.  Association of methylenetetrahydrofolate reductase and methionine synthase polymorphisms with breast cancer risk and interaction with folate, vitamin B6, and vitamin B 12 intakes.

Authors:  Qiao Jiang-Hua; Jiao De-Chuang; Lu Zhen-Duo; Cui Shu-de; Liu Zhenzhen
Journal:  Tumour Biol       Date:  2014-09-13

5.  The methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism is associated with breast cancer subtype susceptibility in southwestern China.

Authors:  Zhen Li; Ji Zhang; Wei Zou; Qi Xu; Siyuan Li; Jie Wu; Li Zhu; Yunjiao Zhang; Lei Xu; Ying Zhang; Qingsong Luo; Jianyun Nie; Xingxu Li; Tianning Zou; Ceshi Chen
Journal:  PLoS One       Date:  2021-07-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.